Having trouble accessing articles? Reset your cache.

Disney lab uncovers another RNA-binding small molecule for triple-negative breast cancer

The Disney lab expands its RNA-binding small molecule toolbox with targeted RNA degradation

Matthew Disney is attacking triple-negative breast cancer again with the latest iteration of his RNA-binding small molecule technology, which marries the concept with targeted RNA degradation to eliminate disease-causing RNA segments.

In a paper published in the Proceedings of the National Academy of Sciences (PNAS) on Jan. 20, Disney and colleagues showed that a small molecule construct designed to degrade the

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers